Urogenital Tract Infection

Table. 4.

Broad-spectrum antibiotics

Antibiotics change Prostatic abscess size (cm) Patient number Etiology Medical history
Cepha→Carba A #6 No growth
Cepha→Carba A #7 No growth Lt. orchitis, allergic history
Cepha→Carba→Cefepime B #17 Pseudomonas aeruginosa; cefepime S Pelvic bone fracture surgery history
Cepha→Carba→Cefepime B #21 ESBL+ Klebsiella pneumoniae; all S Liver abscess, neutropenia
Cepha→Tazo A #9 No growth
Cepha→Tazo B #12 No growth
Cepha→Tazo B #23 Pseudomonas otitidis; cefepime S
FQ→Carba A #4 ESBL+ Escherichia coli; ertapenem S Rt. PCN d/t Rt. UPJO
FQ→Carba+Vanco B #16 Staphylococcus aureus; all S Tb, CAOD
FQ+Tazo→Carba+Vanco B #19 No growth Lung abscess, expire

Cepha: 3rd generation cephalosporins, Carba: carbapenems, Tazo: piperacillin/tazobactam, FQ: fluoroquinolones, Vanco: vancomycin, ESBL: extended-spectrum beta-lactamase, Lt.: left, Rt.: right, PCN: percutaneous nephrostomy, UPJO: uretero-pelvic junction obstruction, Tb: tuberculosis, CAOD: coronary artery occlusive disease.

Urogenit Tract Infect 2022;17:96-102 https://doi.org/10.14777/uti.2022.17.3.96
© 2022 Urogenit Tract Infect